Adagene Inc. (ADAG)
NASDAQ·Healthcare·Biotechnology
$1.99
-1.49%
Mkt Cap $115.00M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$8.67
Range $7.00 – $10.00
Implied Upside
+335.7%
Consensus $8.67 vs current $1.99
NASDAQ·Healthcare·Biotechnology
$1.99
-1.49%
Mkt Cap $115.00M
No recent rating data.
Price Target (5 analysts)
$8.67
Range $7.00 – $10.00
+335.7%
Consensus $8.67 vs current $1.99